Sort
82,697 grants matching “vaccine development”
Germline targeting influenza immunogens
$1,417,715David Nemazee · Scripps Research Institute, The · R01 · FY2017 · AI
Emerging Infections Program
$1,417,714Timothy F. Jones · Tennessee State Department Of Health · U01 · FY2011 · CI
Enhancing the antiviral memory B cell response
$1,417,500Brian Laidlaw · Washington University · DP2 · FY2021 · AI
A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses
$1,417,453Kara W Chew · University Of California Los Angeles · U01 · FY2025 · AI
New class of PBP inhibitors to address PBP2-mediated resistance in Neisseria gonorrhoeae
$1,417,435Denis Marc Daigle · Venatorx Pharmaceuticals, Inc. · R01 · FY2020 · AI
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$1,417,336Michael A Pulsipher · Children'S Hospital Of Los Angeles · U01 · FY2017 · AI
DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV
$1,416,167University Of Pittsburgh At Pittsburgh · P01 · FY2000 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$1,416,121John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
$1,416,075Paul Stephen Keim · Northern Arizona University · U19 · FY2024 · AI
Preclinical development of a vaccine for Nipah virus
$1,415,990Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
$1,415,922Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2025 · AI
Application of Flow Cytometry to Cell Biology
$1,415,903Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
San Francisco Bay Clinical Trials Unit (CTU)
$1,415,883Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2024 · AI
Maintenance of an SPF Macaque Breeding Colony for AIDS Research
$1,415,801Kasi E Russell-Lodrigue · Tulane University Of Louisiana · U42 · FY2024 · OD
Maintenance of an SPF Macaque Breeding Colony for AIDS Research
$1,415,801Rudolf P Bohm · Tulane University Of Louisiana · U42 · FY2021 · OD
Maintenance of an SPF Macaque Breeding Colony for AIDS Research
$1,415,801Rudolf P Bohm · Tulane University Of Louisiana · U42 · FY2022 · OD
Maintenance of an SPF Macaque Breeding Colony for AIDS Research
$1,415,801Kasi E Russell-Lodrigue · Tulane University Of Louisiana · U42 · FY2023 · OD
Viral Genomics: evolution, spread, and host interactions
$1,415,767Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2015 · AI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,415,724Shabaana A. Khader · University Of Chicago · R01 · FY2023 · AI
San Francisco Bay Clinical Trials Unit (CTU)
$1,415,682Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2023 · AI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT
$1,415,585David B Clifford · Washington University · UM1 · FY2013 · AI
Preclinical development of a novel antibacterial for Clostridium difficile diseas
$1,415,514George E Wright · Glsynthesis, Inc. · R44 · FY2012 · AI
ESTABLISHMENT OF SPECIFIC PATHOGEN FREE RHESUS AND PIGTA
$1,414,947Michael K Axthelm · Oregon Health & Science University · U24 · FY2006 · RR
HIVRAD: Structural approaches to vaccine development
$1,414,773Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2006 · AI
ECHO Renewal for the CANOE Study Cohort
$1,414,688Tina V Hartert · Vanderbilt University Medical Center · UG3 · FY2024 · OD